ATCC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:ATCC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011832
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ATCC is a nonprofit bioresource center and research organization that provides biological products, technical services and educational programs. The organization acquires, preserves, develops, authenticates, produces, and distributes standard reference microorganisms, cell lines and other materials. Its products include nucleic acids, cells and microorganisms, testing and characterization, cells extracts, culture reagents, quality control strains, proteins and cell extracts. ATCC’s services include production and characterization, biorepository management, testing services, and deposit services. The organization offers custom testing services for mycoplasma detection and human cell line authentication. It serves research and life science industry. The organization also provides storage of biomaterials through its facility. ATCC is headquartered in Manassas, Virginia, the US.

ATCC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ATCC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
ATCC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
ATCC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
ATCC, Medical Devices Deals, 2011 to YTD 2017 8
ATCC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
ATCC, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Horizon Discovery Enters Into Licensing Agreement With ATCC 10
ATCC Forms Joint Venture with ILSE 11
BioCision Enters Into Co-Development Agreement With ATCC 12
Promega Enters Into An Agreement With ATCC 13
ATCC Enters Into Co-Development Agreement With Stemgent 14
Licensing Agreements 15
Heat Biologics Enters into Licensing Agreement with American Type Culture Collection 15
Biomatrica Enters Into Licensing Agreement With ATCC For DNAstable And RNAstable Reagents 16
ATCC Enters into Licensing Agreement with Baylor College of Medicine 17
ATCC Enters Into Licensing Agreement With Life Technologies For GFP Technology 18
ATCC Enters Into Licensing Agreement With iPS Academia Japan 19
ATCC – Key Competitors 20
ATCC – Key Employees 21
ATCC – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Joint Venture 22
Recent Developments 23
Strategy And Business Planning 23
Apr 21, 2017: ATCC Opens Doors to New High-Tech Biorepository in Gaithersburg, MD 23
Corporate Communications 24
May 12, 2016: ATCC Names Dr. Mindy Goldsborough As Chief Science And Technology Officer 24
Product News 25
Nov 20, 2017: ATCC develops novel in vitro model to investigate drug candidates for cancer metastasis 25
Apr 21, 2016: ATCC Launches Custom Cell Lines Funded By The Michael J. Fox Foundation For Parkinson’S Research 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
ATCC, Pharmaceuticals & Healthcare, Key Facts 2
ATCC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
ATCC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
ATCC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
ATCC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
ATCC, Medical Devices Deals, 2011 to YTD 2017 8
ATCC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Horizon Discovery Enters Into Licensing Agreement With ATCC 10
ATCC Forms Joint Venture with ILSE 11
BioCision Enters Into Co-Development Agreement With ATCC 12
Promega Enters Into An Agreement With ATCC 13
ATCC Enters Into Co-Development Agreement With Stemgent 14
Heat Biologics Enters into Licensing Agreement with American Type Culture Collection 15
Biomatrica Enters Into Licensing Agreement With ATCC For DNAstable And RNAstable Reagents 16
ATCC Enters into Licensing Agreement with Baylor College of Medicine 17
ATCC Enters Into Licensing Agreement With Life Technologies For GFP Technology 18
ATCC Enters Into Licensing Agreement With iPS Academia Japan 19
ATCC, Key Competitors 20
ATCC, Key Employees 21
ATCC, Joint Venture 22

★海外企業調査レポート[ATCC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Empired Ltd (EPD):企業の財務及び戦略的SWOT分析
    Summary Empired Ltd (Empired) is a technology consulting company that provides business solutions. The company offers services such as cloud services, expert guidance, identity and access management, system integration, data insights, spatial services, mobile solutions, enterprise content management …
  • Bank CIC (Switzerland) Ltd.:企業の戦略・SWOT・財務情報
    Bank CIC (Switzerland) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Bank CIC (Switzerland) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Emmsons International Ltd:企業の戦略・SWOT・財務分析
    SummaryEmmsons International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. K …
  • NTN Corporation (6472):企業の財務・戦略的SWOT分析
    NTN Corporation (6472) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • TheraDiag SA (ALTER):企業の財務・戦略的SWOT分析
    Summary Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA, is a biotechnology company that develops, manufactures, and markets vitro diagnostic products. The company offers product for the diagnostics of auto-immune diseases, allergies and infectious diseases. It develops product panels f …
  • Emerson Electric Co. (EMR):企業のM&A・提携動向(石油・ガス分野)
    Summary Emerson Electric Co. (Emerson) is a provider of infrastructure technologies and life cycle services for information and communication technology systems. The company offers hardware and software solutions for power, thermal and infrastructure management. It also offers services such as remot …
  • BAVARIA, S.A.:企業概要およびSWOT分析
    Summary Canadean's "BAVARIA, S.A.: Consumer Packaged Goods - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company h …
  • N Brown Group plc:企業の戦略・SWOT・財務情報
    N Brown Group plc - Strategy, SWOT and Corporate Finance Report Summary N Brown Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Enel Americas SA:企業の戦略・SWOT・財務情報
    Enel Americas SA - Strategy, SWOT and Corporate Finance Report Summary Enel Americas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Mariner Holdings LLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Mariner Holdings LLC Mergers an …
  • Visteon Corporation:企業の戦略・SWOT・財務情報
    Visteon Corporation - Strategy, SWOT and Corporate Finance Report Summary Visteon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Wilmar International Limited:企業の戦略・SWOT・財務分析
    SummaryWilmar International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company …
  • Insmed Incorporated:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Insmed Incorporated Mergers and …
  • Reece Energy Exploration Corp.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Reece Energy Exploration Corp. …
  • Power Integrations, Inc. (POWI):企業の財務及び戦略的SWOT分析
    Summary Power Integrations, Inc. (Power Integrations) is an electric equipment company that supplies electronic components used in high-voltage power-conversion systems. The company’s products include chiphy, LYTswitch, linkzero, linkswitch, potswitch, hiper, capzero, senzero, dpa-switch and qspeed. …
  • BirchBioMed Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary BirchBioMed Inc (BirchBioMed) is a biomedical company that concentrate on the development, clinical evaluation and commercialization of anti-scarring drugs, autoimmune therapeutics and novel strategies for transplantation. The company’s proprietary and patented lead drug candidate, FS2 is be …
  • PaperlinX Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' PaperlinX Limited Mergers and A …
  • Korab Resources Ltd (KOR):企業の財務・戦略的SWOT分析
    Summary Korab Resources Ltd (Korab) is a mining exploration company. The company’s business activities include evaluation, exploration, acquisition, production, and development of mineral resource properties. It explores for gold, potash, silver, tin, copper, rare earths, nickel, lead, zinc, magnesi …
  • Martin Resource Management Corp.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Martin Resource Management Corp …
  • Pharm-Olam International Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Pharm-Olam International Ltd (Pharm-Olam) is a contract research organization (CRO) which offers clinical research services to the pharmaceutical, biotechnology and medical device industries. The organization's service offerings include medical writing, monitoring, regulatory and ethics subm …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆